A recent study carried out at the University of Florida Proton Therapy Institute concluded that proton therapy following chemotherapy has a success rate similar to conventional treatments for Hodgkin Lymphoma. It also concluded that proton therapy is a much safer alternative as it does not result in latter effects of conventional radiotherapy like breast cancer and heart disease.
The study tracked 15 patients from September 2009 until June 2013. This study supports the use of proton therapy for positive long-term treatment outcomes and reduced damage to the surrounding tissue. These are early stage results but emphasis the potential of proton therapy to treat not only children and head/neck tumors but complicated later stage cancers like Hodgkin's disease.
International Journal of Radiation Oncology, Biology and Physics